Fig. 3From: Evaluation of therapeutic potential of VB-001, a leave-on formulation, for the treatment of moderate adherent dandruffComparison of patients showing improvement in scalp flaking during the course of the study. Bar graphs show percentage of patients reaching an ASFS of less than 5 at the indicated days of the trial in VB-001 group versus ZPTO shampoo groupBack to article page